Effects of <i>trans ε</i>-viniferin at 10 mg/kg on amyloid deposits and neuroinflammation in cortex. by Martial Caillaud (6383672)

Effects of <i>trans ε</i>-viniferin at 10 mg/kg on amyloid deposits and neuroinflammation in hippocampus. by Martial Caillaud (6383672)

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. by Rene Bilingwe Ayiseh (6900296)

Boron Leaching Decreases withIncreases on Soil pH by Alessandra Aparecida de Sá (12700698)

“…The experiment was carried out in the laboratory in 2012, and treatments consisted of a factorial combination of two rates of liming (without and with lime to raise the soil pH to 6.0) and five rates of B (0, 10, 20, 50 and 100 mg kg-1, as boric acid). …”

Fig 2 - by Nida Mansoora (11648641)

Subjects:

Fig 3 - by Nida Mansoora (11648641)

Subjects:

Fig 4 - by Nida Mansoora (11648641)

Subjects:

Fig 1 - by Nida Mansoora (11648641)

Subjects:

The cytoplasmic leaflet of the TGN in the Neo1p-depleted <i>cfs1</i>Δ <i>erd1</i>Δ mutant contains PS and decreased level of PI4P. by Mamoru Miyasaka (9187916)

Effects of busulfan treatment (6 mg/kg) on the epididymis and sperm of mice over a three-week period. by Lingjun Zhao (21763122)

“…<p>(A) The epididymal sperm concentrations decrease over time and significantly differ between hour 0 (control) and day 21 (<i>n </i>= 3 per group). …”

Heart specific RNase Z variants show a mild decrease in longevity and locomotor response. by Ekaterina Migunova (15909887)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Patients’ clinicopathological characteristics. by Da young Yu (20536611)

Subjects:

Oncologic results. by Da young Yu (20536611)

Subjects:

Perioperative parameters. by Da young Yu (20536611)

Subjects:

Perioperative complications. by Da young Yu (20536611)

Subjects:

Effect of control or Notch3 ASOs administered subcutaneously to C57BL/6 wild type mice on <i>Notch3</i> mRNA. by Ernesto Canalis (516050)

Subjects:

Effect of control or Notch3 ASOs on <i>Notch3</i> mRNA expression and cell replication in calvarial osteoblast-enriched cells. by Ernesto Canalis (516050)

Subjects: